SMA Archives | DelveInsight Business Research

Tag: SMA

Spinal Muscular Atrophy Therapies

How Spinal Muscular Atrophy Therapies transform market?

Aug 30, 2019• Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Oncology based Reports, Pharma Consultant

US approval to Lundbeck’s Vyepti for preventive migraine care; Esperion’s cholesterol-lowering drug Nexletol receives FDA nod; Karius – a start-up company – raises USD 165 Million – strengthens it liquid biopsy testing
Business Consultant, News, Pharma Consultant
Opioid Withdrawal Syndrome: What happens when a person withdraws from Opiates
Articles, Business Consultant, Pharma Consultant
Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players
Articles, Business Consultant, Pharma Consultant
Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust
Business Consultant, Pharma Consultant, Pharma news
Cardiovascular Disease: A major cause of health loss and a global burden
Business Consultant, Pharma Consultant, Snippets
Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?
Chimeric Antigen Receptor (CAR) T-cell Therapy
Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade
Articles, Business Consultant, Pharma Consultant
Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D
Articles, Business Consultant, Pharma Consultant
J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug
Business Consultant, News, Pharma Consultant
The epidemic now has a name: COVID-19
Articles, Business Consultant, Pharma Consultant